Safety Notices

From time to time notices relating to the safety, efficacy and quality of human medicinal products are published by the Health Products Regulatory Authority.

The issues covered by these notices include medicinal product safety information, updated efficacy information on the appropriate usage of medicines and quality defect information.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General information provided by 3rd parties as approved by the HPRA, e.g. MIMS, Direct Healthcare Professional Letter or Product Information Update

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
29/06/2022 Medicinal Product Shortages – update – 29 June 2022 Advisory
27/06/2022 Risks of using Melanotan 2 Advisory
22/06/2022 Medicinal Product Shortages – update – 22 June 2022 Advisory
15/06/2022 Medicinal Product Shortages – update – 15 June 2022 Advisory
08/06/2022 Medicinal Product Shortages – update – 8 June 2022 Advisory
01/06/2022 Medicinal Product Shortages – update – 1 June 2022 Advisory
25/05/2022 Medicinal Product Shortages – update – 25 May 2022 Advisory
19/05/2022 Safety Update: COVID-19 Vaccines — Overview of National Reporting Experience — 19 May 2022 Advisory
11/05/2022 Medicinal Product Shortages – update – 11 May 2022 Advisory
04/05/2022 Medicinal Product Shortages – update – 4 May 2022 Advisory